Multiple drugsGrade 4 Cytokine-release-syndrome and lack of efficacy followed by off-label-use: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2022年 / 1927卷 / 1期

关键词：

D O I：

10.1007/s40278-022-25096-y

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：360 / 360

相关论文

共 50 条

[1] Multiple drugsGrade 4 neutropenia following off label use and lack of efficacy: case report
Reactions Weekly, 2025, 2046 (1) : 269 - 269
[2] Multiple drugsGrade 2 local cytokine release syndrome and lack of efficacy: case report
Reactions Weekly, 2024, 2027 (1) : 300 - 300
[3] Multiple drugsGrade 2 fatigue, lack of efficacy and off label use: case report
Reactions Weekly, 2024, 2023 (1) : 258 - 258
[4] Multiple drugsDrug resistance, off-label-use and lack of efficacy: case report
Reactions Weekly, 2022, 1931 (1) : 389 - 389
[5] PembrolizumabHypothyroidism, off-label-use and lack-of-efficacy: case report
Reactions Weekly, 2022, 1920 (1) : 397 - 397
[6] Multiple drugLack of efficacy and off-label-use: case report
Reactions Weekly, 2022, 1936 (1) : 313 - 313
[7] Multiple drugsCOVID-19 pneumonia, cytokine release syndrome, off label use and lack of efficacy: case report
Reactions Weekly, 2023, 1986 (1) : 273 - 273
[8] Multiple drugsLack of efficacy and off-label-use: case report
Reactions Weekly, 2021, 1881 (1) : 179 - 179
[9] Multiple drugsLack of efficacy and off-label-use: case report
Reactions Weekly, 2025, 2048 (1) : 265 - 265
[10] AntineoplasticsLack of efficacy, cytokine release syndrome and off label use: case report
Reactions Weekly, 2022, 1935 (1) : 64 - 64

← 1 2 3 4 5 →